antibodi
crucial
part
immun
respons
toward
invad
pathogen
virus
induct
socal
neutral
antibodi
primari
goal
vaccin
addit
great
interest
develop
broadli
neutral
antibodi
specif
major
human
pathogen
human
immunodefici
viru
hiv
influenza
viru
neutral
virus
antibodi
predict
depend
highaffin
bind
specif
epitop
surfaceexpos
viral
protein
requir
bind
target
cell
receptor
antibodi
thought
function
accord
occup
model
requir
bind
critic
number
antibodi
viral
particl
way
neutral
epitop
occupi
may
occur
independ
concert
antibodymedi
effector
function
antibodydepend
cellular
phagocytosi
antibodydepend
cellular
cytotox
effector
function
induc
upon
bind
immun
complex
classic
fc
receptor
express
surfac
hematopoiet
cell
natur
killer
nk
cell
macrophag
dendrit
cell
result
clearanc
induct
tcell
respons
neutral
antibodi
also
prevent
infect
concert
nonclass
fc
receptor
neonat
fc
receptor
fcrn
polymer
ig
receptor
pigr
fcrn
mediat
bidirect
transport
igg
across
mucos
epitheli
surfac
pigr
mediat
unidirect
transcytosi
iga
igm
tissu
lumin
space
transcellular
transport
neutral
also
nonneutr
antibodi
shown
facilit
protect
viral
infect
although
neutral
antibodi
produc
antivir
respons
major
antibodi
polyclon
respons
neutral
activ
classic
definit
due
fact
bind
intern
viral
epitop
releas
infect
lyse
cell
viral
surfac
protein
involv
viral
attach
entri
host
cell
addit
virus
known
display
immunedomin
nonneutr
epitop
bia
polyclon
respons
toward
nonneutr
phenotyp
neutral
virus
antibodi
recent
assum
sole
extracellular
intravesicular
event
howev
recent
year
becom
clear
antivir
function
antibodi
also
extend
cytosol
compart
cell
addit
level
protect
orchestr
interferon
ifn
induc
cytosol
fc
receptor
tripartit
motif
engag
result
rapid
postentri
elimin
via
recruit
proteasom
machineri
mechan
term
antibodydepend
cellular
neutral
adin
concurr
inflammatori
signal
also
induc
therefor
antibodi
fail
block
entri
viru
particl
cell
intercept
antibodymedi
effector
function
oper
extracellular
environ
may
still
protect
cytosol
compart
even
though
classic
definit
nonneutr
instead
cell
take
advantag
set
one
last
line
antivir
defens
distinguish
fc
receptor
two
way
firstli
show
remark
broad
antibodi
specif
activ
function
upon
bind
igg
igm
well
iga
fc
receptor
display
restrict
antibodi
isotyp
subtyp
specif
secondli
broadli
express
cell
histogen
linag
express
classic
mainli
restrict
hematopoiet
cell
suggest
suscept
pathogen
may
target
independ
site
infect
local
distribut
antibodi
isotyp
interact
first
describ
yeast
twohybrid
screen
studi
investig
role
autoantigen
immun
disord
system
lupu
erythematosu
syndrom
refer
ssa
subsequ
studi
immunoprecipit
independ
antibodi
specif
bind
site
postul
local
interfac
fc
found
compet
bind
staphylococcu
protein
streptococcu
protein
g
furthermor
correspond
bind
site
found
local
ctermin
pryspri
domain
truncat
domain
result
loss
bind
although
interact
igg
initi
thought
irrelev
due
topolog
distinct
local
two
protein
specif
role
antivir
defens
recent
describ
fc
receptor
structur
unrel
class
fc
receptor
part
trim
famili
consist
member
human
divers
set
cellular
role
includ
antivir
defens
one
studi
member
mediat
restrict
simian
immunodefici
viru
via
antibodyindepend
mechan
share
structur
architectur
trim
protein
consist
ntermin
ring
domain
ubiquitin
ligas
activ
bbox
central
coiledcoil
domain
refer
rbcc
howev
ctermin
domain
trim
protein
determin
ligand
specif
function
half
known
trim
protein
socal
pryspri
domain
pryspri
domain
contain
antibodi
bind
site
globular
fold
compris
two
antiparallel
connect
flexibl
loop
fusion
pri
spri
element
distinct
evolutionari
origin
furthermor
trim
protein
known
form
dimer
higher
order
structur
via
coiledcoil
domain
heteromer
homomer
trim
describ
crystallograph
data
coiledcoil
reveal
antiparallel
helic
structur
place
ntermin
ring
domain
opposit
side
dimer
structur
ctermin
pryspri
domain
posit
center
although
crystal
structur
fulllength
yet
solv
presenc
coiledcoil
suggest
adopt
similar
structur
arrang
would
place
two
pryspri
domain
close
proxim
consist
fulllength
shown
exist
dimer
solut
form
stabl
complex
human
thu
two
pryspri
domain
dimer
molecul
may
bind
simultan
one
igg
fc
symmetr
mode
bind
allow
rapidli
intercept
incom
antibodi
detail
understand
interact
obtain
solv
cocryst
structur
ctermin
pryspri
domain
human
fc
fragment
deriv
human
complex
reveal
stoichiometri
pryspri
domain
bind
interfac
found
side
fc
bind
site
distinct
classic
lower
hing
domain
overlap
bind
site
fcrn
well
bacteri
viral
fc
receptor
contrast
bind
neither
fcrn
bind
igg
affect
remov
glycan
domain
core
interact
site
form
spri
element
domain
igg
fc
protrud
conserv
fc
loop
encompass
residu
insert
deep
hydrophob
pocket
spri
surfac
apex
fc
residu
hnh
motif
form
central
hydrogen
bond
network
surround
hydrophob
shield
aromat
side
chain
engag
aromat
stack
interact
specif
interact
locat
base
spri
bind
pocket
via
hydrogen
bond
also
interact
via
aromat
stack
may
also
involv
furthermor
form
hydrogen
bond
stack
addit
loop
encompass
residu
involv
hydrophob
interact
overview
cocryst
complex
interact
network
present
fig
contrast
strict
ph
depend
interact
bind
fc
ph
independ
sensit
high
salt
concentr
interact
shown
highli
conserv
mammal
display
wide
crossspeci
reactiv
human
mous
bind
igg
rang
mammal
support
inspect
cocryst
structur
mous
pryspri
domain
fc
fragment
deriv
mous
show
mous
human
mode
bind
highli
similar
bind
affin
human
igg
monomer
human
pryspri
domain
measur
nm
use
isotherm
titrat
calorimetri
murin
interact
affin
nm
human
interact
occur
neg
enthalpi
howev
fact
fulllength
dimer
molecul
direct
implic
function
affin
antibodi
two
pryspri
domain
dimer
molecul
may
bind
simultan
one
igg
fc
suggest
crystal
structur
simultan
engag
heavi
chain
like
explain
significantli
increas
interact
dimer
yield
affin
nm
interact
measur
fluoresc
anisotropi
notabl
repres
increas
rel
monomer
affin
make
highest
affin
fc
receptor
human
fc
receptor
highli
select
regard
isotyp
subtyp
bind
bind
igg
also
igm
iga
interestingli
bind
site
iga
igm
overlap
fc
receptor
receptor
pigr
well
sever
pathogenproduc
fc
receptor
bind
affin
igm
iga
toward
monomer
human
pryspri
consider
weaker
measur
respect
howev
despit
rel
weak
monomer
bind
dimer
natur
fulllength
suggest
function
affin
igm
iga
much
stronger
assum
increas
monomer
affin
upon
bind
fulllength
igg
similar
igm
iga
bind
strength
may
submicromet
rang
physiolog
condit
weak
monomer
bind
igm
iga
like
due
sequenc
variat
stretch
amino
acid
correspond
igg
specif
apex
hnh
motif
igg
pnr
igm
pla
iga
howev
bind
still
accommod
structur
conserv
fc
loop
among
three
isotyp
address
molecular
model
show
structur
loop
igg
igm
superimpos
close
secondari
structur
level
allow
insert
hydrophob
pryspri
bind
pocket
although
individu
mutat
murin
antibodi
shown
abolish
recognit
specif
replac
igm
iga
predict
form
specif
interact
pryspri
residu
igm
conserv
central
thought
crucial
hydrogen
bond
potenti
like
maintain
replac
prolin
abolish
hydrogen
bond
potenti
abil
interact
two
fc
residu
simultan
howev
prolin
residu
may
still
interact
even
though
pair
true
aromat
stack
gener
bind
energi
roughli
doubl
hydrogen
bond
furthermor
replac
arginin
igm
abolish
aromat
stack
potenti
arginin
may
still
bind
given
favor
side
chain
conform
iga
correspond
igg
thought
similar
role
igm
presenc
equival
igg
interact
instead
thought
form
hydrophob
contact
predict
contribut
bind
structur
predict
interact
igm
iga
shown
fig
infect
nonenvelop
viru
antibodi
attach
viral
capsid
also
carri
cytosol
compart
target
cell
recogn
fig
subsequ
engag
target
viru
proteasom
degrad
time
replic
spread
first
demonstr
use
human
adenoviru
type
carri
green
fluoresc
protein
report
gene
model
pathogen
incub
antiadv
polyclon
serum
goat
upon
infect
hela
cell
protect
infect
found
correl
level
express
deplet
gave
high
infect
level
upregul
stimul
increas
adin
follow
endocytosi
via
coxsacki
adenoviru
receptor
car
complex
nonneutr
antibodi
lyse
endosom
membran
enter
cytosol
intercept
engag
result
autoubiquitin
manner
depend
upon
activ
ring
domain
ubiquitin
lead
recruit
proteasom
machineri
rapid
degrad
viral
complex
process
perturb
proteasom
inhibitor
epoxomicin
degrad
process
demonstr
strictli
depend
aaa
atpas
vcp
multidomain
protein
complex
interact
directli
multiubiquitin
chain
via
ntermin
domain
capabl
extract
protein
larger
complex
well
unfold
therefor
gener
role
vcp
preproteasom
degrad
step
suggest
vcp
recent
found
recruit
stall
proteasom
consid
intact
adv
capsid
measur
nm
diamet
diamet
proteasom
barrel
nm
predisassembl
step
intuit
requir
like
challeng
natur
viral
capsid
rather
intrins
featur
adin
result
vcp
depend
mediat
proteasom
turnov
ectop
express
igg
fc
independ
vcp
fast
rate
adin
crucial
must
occur
adv
reach
nucleu
initi
replic
demonstr
use
fateofcapsid
assay
cellular
level
major
capsid
protein
hexon
degrad
within
h
infect
adin
mechan
strictli
depend
ubiquitin
substrat
attach
ubiquitin
ubiquitin
machineri
involv
four
enzym
ubiquitin
activ
ubiquitin
conjug
substrat
specifi
ubiquitin
ligas
well
ubiquitin
eras
deubiquitinas
dub
respons
ubiquitin
chain
linkag
topolog
enzym
recent
shown
mediat
attach
monoubiquitin
make
access
substrat
enzym
pair
result
extens
ubiquitin
chain
vitro
furthermor
demonstr
requir
attach
ubiquitin
chain
cell
attach
ubiquitin
chain
thought
result
target
proteasom
undergo
autoubiquitin
could
allow
effect
divers
rang
pathogen
hypothesi
support
fact
antibodyco
bead
transfect
cell
becom
posit
ubiquitin
suggest
cytosol
particl
bound
antibodi
potenti
target
adin
initi
stage
antibodi
respons
igm
main
antibodi
isotyp
produc
igm
form
pentam
associ
common
join
chain
jchain
iga
main
isotyp
mucos
barrier
second
preval
isotyp
serum
mgml
compar
mgml
igg
two
subclass
iga
exist
express
monomer
miga
dimer
diga
secretori
siga
form
serum
preval
form
domin
mucos
site
immun
complex
contain
interact
mediat
phagocytosi
cellular
cytotox
antigen
present
cytokin
releas
profession
cell
equival
classic
igg
iga
igm
bind
pigr
mediat
transport
tissu
lumen
bodi
caviti
upon
releas
associ
pigrderiv
secretori
compon
sc
form
siga
sigm
interestingli
scbind
site
iga
overlap
bind
site
although
sc
thought
associ
one
heavi
chain
iga
monom
may
explain
weak
affin
siga
pryspri
domain
infect
igm
igabound
antibodi
recogn
direct
elimin
viru
via
adin
demonstr
human
igm
iga
isol
serum
observ
igg
stimul
increas
neutral
manner
isotyp
despit
reduc
affin
siga
virusspecif
siga
human
serum
found
activ
adin
cellular
deplet
partial
restor
viral
infect
although
presenc
sc
appear
inhibit
function
data
suggest
disulfid
bond
iga
sc
may
broken
upon
exposur
reduc
environ
cytosol
allow
attach
interestingli
recent
studi
demonstr
siga
form
trimer
tetram
nasal
secret
healthi
adult
contribut
enhanc
neutral
potenc
higher
form
siga
may
like
reach
cytosol
togeth
pathogen
intrigu
featur
adin
mechan
antibodi
per
viru
requir
effect
adin
activ
close
correl
express
level
rather
extent
opson
viru
nonentri
block
antibodi
use
murin
monoclon
antibodi
specif
major
capsid
protein
adv
hexon
nonentri
neutral
epitop
togeth
manipul
cellular
level
use
shrna
allow
investig
antibodi
viru
contribut
effici
neutral
cell
express
high
level
antibodi
molecul
per
viru
found
suffici
neutral
five
time
antibodi
requir
unstimul
cell
furthermor
adin
found
increas
linearli
increment
manner
demonstr
antibodi
associ
viru
contribut
equal
elimin
upon
bind
contrast
occup
model
entri
neutral
effici
prevent
infect
occur
critic
number
antibodi
occupi
specif
viral
epitop
involv
cellular
attach
entri
consequ
result
lag
phase
neutral
curv
infect
level
plot
antibodi
concentr
critic
number
antibodi
requir
block
entri
reach
find
support
data
demonstr
polyclon
serumcontain
antibodi
specif
requir
higher
stoichiometri
neutral
occur
cellular
deplet
indic
shift
cytosol
adin
entri
block
thu
polyclon
respons
contain
entri
neutral
antibodi
adin
may
respons
major
neutral
activ
low
stoichiometri
may
also
result
ineffici
effector
function
immun
cell
effici
phagocytosi
requir
format
immun
complex
crossbind
cellsurfac
addit
also
engag
igm
iga
like
contribut
earli
protect
gate
entri
viral
pathogen
mucos
barrier
howev
mean
protect
becom
irrelev
later
stage
infect
amount
entri
neutral
antibodi
high
affin
like
increas
infect
sever
virus
shown
occur
even
satur
level
entri
neutral
antibodi
viru
particl
still
infect
target
cell
condit
known
persist
fraction
case
magnitud
persist
fraction
shown
correl
express
level
consider
increas
persist
infect
level
measur
upon
deplet
adin
also
satur
high
viral
load
support
notion
level
determinist
suggest
could
overcom
pathogen
high
level
viremia
efficaci
adin
also
depend
cellular
compon
vcp
proteasom
express
level
rate
enzymat
turnov
compon
also
like
affect
abil
induc
adin
extracellular
detect
immun
complex
cellsurfaceexpress
result
phosphoryl
intracellular
immunoreceptor
tyrosinebas
activ
motif
trigger
phagocytosi
immun
activ
known
mechan
detect
pathogen
intracellular
environ
occur
independ
antibodi
instead
depend
upon
recognit
pathogenassoci
molecular
pattern
achiev
via
pathogen
recognit
receptor
prr
tolllik
receptor
cytosol
receptor
viral
nucleic
acid
retino
acidinduc
melanomadifferenti
associ
protein
immun
system
also
activ
tissu
damag
result
pathogen
replic
via
misloc
selfmolecul
host
deriv
factor
known
damageassoci
molecular
pattern
damp
even
though
concentr
igg
human
serum
high
mgml
exclud
cytosol
compart
cell
normal
physiolog
circumst
howev
infect
antibodi
igg
igm
iga
isotyp
enter
cytosol
bound
pathogen
act
like
damp
upon
recognit
importantli
addit
adin
engag
induc
antivir
state
activ
inflammatori
respons
unanchor
ubiquitin
immun
second
messeng
activ
transcript
factor
pathway
via
enzym
complex
inhibit
complex
prevent
signal
whenev
ubiquitinmodifi
substrat
target
proteasom
three
dub
regulatori
particl
remov
ubiquitin
substrat
degrad
recent
demonstr
cell
deplet
unabl
activ
signal
respons
complex
suggest
cleav
ubiquitin
chain
therebi
activ
innat
signal
respons
assur
induc
signal
respons
viru
antibodi
complex
target
proteasom
destruct
mechan
prevent
adin
antagon
signal
rapid
degrad
viru
thu
synchron
activ
two
effector
function
activ
innat
signal
pathway
induc
rapid
product
proinflammatori
cytokin
chemokin
shown
occur
primari
human
lung
fibroblast
monocyt
specif
cytokin
well
chemokin
detect
respons
iggcoat
furthermor
shown
inflammatori
signal
induc
sole
upon
detect
independ
known
prr
chemic
inhibit
trif
tyrosin
kinas
syk
knockdown
cytosol
impact
signal
activ
sens
place
cell
antivir
state
involv
increas
express
major
histocompat
complex
class
mhc
well
activ
mhc
ilik
ligand
nonhematopoiet
cell
engag
result
rapid
degrad
viral
protein
well
inflammatori
signal
upregul
express
mhc
possibl
peptid
deriv
viru
could
transport
via
transport
associ
antigen
process
tap
load
onto
mhc
molecul
would
make
cell
target
cytotox
effect
nk
cell
cell
howev
yet
test
experiment
principl
cell
could
cure
infect
adin
rather
kill
effector
lymphocyt
induct
cell
kill
lymphocyt
requir
cluster
mhc
molecul
tcell
receptor
may
specul
level
infect
could
factor
determin
whether
cell
would
clear
viru
sole
via
adin
tcell
help
requir
import
question
induct
signal
via
regul
immun
system
evolv
specif
mechan
prevent
excess
inflamm
regul
must
also
activ
context
classic
achiev
regul
express
level
activ
receptor
inhibitori
detect
cytosol
antibodi
result
synchron
activ
effector
signal
respons
must
strict
regul
avoid
excess
inflamm
low
pathogen
load
may
result
differ
requir
activ
downstream
ubiquitindepend
process
must
relat
detect
incom
complex
potenti
also
selflimit
signal
stimulu
ie
intracellular
antibodi
also
rapidli
degrad
effector
mechan
full
spectrum
pathogen
activ
adin
signal
yet
determin
howev
effector
sensori
function
strictli
depend
presenc
antibodi
cytosol
mechan
pathogen
enter
cell
crucial
regard
viral
infect
main
target
nonenvelop
virus
envelop
virus
shed
outer
membran
coat
upon
fusion
plasma
endosom
membran
deliv
nucleocapsid
cytosol
therefor
antibodi
left
behind
cell
membran
insid
endosom
vesicl
line
envelop
respiratori
syncyti
viru
rsv
detect
ad
cell
complex
antirsv
antibodi
nonenvelop
virus
may
also
avoid
detect
due
rout
infect
exampl
rhinovirus
famili
picornavirida
thought
inject
genom
pore
endosom
membran
therebi
leav
nucleocapsid
attach
antibodi
behind
insid
endosom
case
adv
interact
cellsurfaceexpress
car
trigger
endocytosi
viru
escap
endosom
enter
cytosol
lyse
endosom
membran
process
reli
partial
uncoat
viru
exposur
intern
capsid
protein
induc
membran
damag
insid
cytosol
subvir
particl
use
microtubuleassoci
motor
protein
reach
nuclear
membran
subsequ
dock
nuclear
pore
complex
viral
genom
enter
nucleu
therefor
attach
antibodi
readili
access
recognit
virus
may
also
differ
suscept
detect
due
behavior
reach
cytosol
compart
although
like
virus
evolv
evad
even
take
advantag
part
uncoat
mechan
rapid
detect
stage
prior
synthesi
new
viral
protein
well
bridg
antibodi
may
make
detect
particularli
difficult
antagon
inde
neutral
sever
nonenvelop
virus
antibodi
molecul
describ
adv
papillomavirus
polioviru
importantli
sens
restrict
viru
infect
activ
antibodydepend
signal
respons
intracellular
bacterium
salmonella
enterica
traffic
intracellular
vesicl
cytosol
immun
signal
shown
even
potent
upon
infect
salmonella
mutant
fail
maintain
vesicl
integr
result
greater
proport
bacteria
cytosol
although
bacteria
presum
larg
degrad
proteasom
adin
elimin
adv
shown
happen
independ
autophagi
possibl
link
format
autophagosom
context
salmonella
suggest
fact
evolut
maintain
strong
bind
antibodi
across
speci
point
import
host
defens
humor
immun
cours
infect
occur
varieti
differ
mechan
rel
contribut
depend
natur
pathogen
well
polyclon
antibodi
respons
therefor
address
whether
make
signific
contribut
system
protect
case
must
studi
context
immun
serum
rais
natur
pathogen
far
investig
vitro
vivo
use
wildtyp
mous
adenoviru
caus
hemorrhag
enceph
mice
recov
acut
infect
mice
need
robust
antibodi
respons
abil
serum
neutral
assess
cell
deriv
wildtyp
knockout
mous
embryon
fibroblast
signific
proport
neutral
furthermor
upregul
express
ifn
stimul
increas
adin
potenc
pool
serum
immun
serum
collect
individu
mice
import
protect
vivo
studi
compar
wildtyp
mice
upon
challeng
shown
naiv
mice
lack
higher
viral
load
increas
mortal
within
first
week
infect
experi
perform
naiv
anim
protect
presum
result
interact
igm
passiv
transfer
experi
use
antisera
demonstr
surviv
close
correl
express
transfer
serum
fulli
protect
wildtyp
mice
heterozyg
anim
express
intermedi
level
show
haploinsuffici
phenotyp
compar
mortal
mice
homozyg
null
averag
brain
viral
load
intermedi
wildtyp
knockout
anim
end
point
experi
moreov
agreement
vitro
find
ifn
induct
correl
increas
express
reduc
infect
highlight
import
effici
adin
activ
earli
antiserum
dilut
late
antiserum
depend
protect
compar
nondilut
late
antiserum
indic
antibodymedi
mechan
entri
neutral
incomplet
protect
function
becom
increasingli
import
abl
oper
condit
antibodi
per
viru
addit
use
fulli
replic
wildtyp
viru
studi
demonstr
effect
spread
infect
pathogen
enter
bodi
mucos
surfac
rais
intrigu
question
whether
activ
polar
epitheli
cell
iga
igm
bind
pigr
mediat
transport
basolater
apic
surfac
detect
virus
intracellularli
may
direct
transcytosi
apic
surfac
regard
igg
fcrn
mediat
bidirect
transport
monomer
igg
iggimmun
complex
across
polar
cellular
layer
fcrn
even
shown
facilit
neutral
specif
case
phdepend
antibodi
influenza
neutral
antibodycontain
endosom
undergo
fcrn
transport
fuse
viruscontain
acid
endosom
howev
unpick
antivir
contribut
immunoglobulin
transport
receptor
like
fcrn
vivo
complic
role
determin
antibodi
serum
halflif
biodistribut
engin
improv
fcrn
bind
shown
increas
serum
halflif
enhanc
mucos
local
superior
protect
intrarect
infect
simianhiv
mechanist
correl
properti
determin
mani
exampl
virus
hijack
antibodi
transport
receptor
facilit
infect
whether
fcrn
pigr
directli
prevent
infect
crosstalk
endosom
receptor
intercept
virus
bound
antibodi
remain
address
infect
detect
antibodi
carri
pathogen
cytosol
antibodi
detect
mediat
adin
highli
effici
viral
elimin
mechan
concomitantli
activ
proinflammatori
signal
result
protect
respons
although
complet
spectrum
pathogen
suscept
yet
determin
fast
rate
detect
adaptor
function
antibodi
believ
make
antagon
part
viru
particularli
difficult
therefor
like
divers
nonenvelop
virus
target
shown
make
signific
contribut
system
protect
therebi
provid
import
immun
defens
alongsid
extracellular
mechan
addit
abil
interact
three
antibodi
isotyp
uniqu
featur
among
known
fc
receptor
togeth
broad
express
profil
allow
function
stage
immun
respons
divers
site
although
antibodi
bind
properti
antivir
function
well
establish
sever
question
regard
biolog
remain
unansw
particular
interest
effector
signal
respons
regul
order
avoid
excess
inflamm
arm
function
depend
complex
sequenti
ubiquitin
process
result
synchron
activ
regul
may
depend
differ
activ
threshold
downstream
ubiquitindepend
process
also
import
address
synerg
immun
respons
instanc
adin
may
contribut
crosspresent
viral
peptid
mhc
class
molecul
result
recruit
cytotox
lymphocyt
infect
cell
promiscu
antibodi
bind
function
implic
larg
unexplor
isotypespecif
respons
might
elicit
instanc
bind
four
subtyp
human
igg
known
whether
use
infect
result
differ
respons
moreov
four
igg
subclass
differ
significantli
abil
interact
classic
fc
receptor
activ
could
alter
indirectli
main
gateway
viral
pathogen
bodi
via
mucos
surfac
rais
intrigu
question
whether
make
signific
contribut
protect
bodi
site
whether
function
intersect
transepitheli
transport
antibodi
fcrn
pigr
recent
demonstr
complement
factor
attach
differ
nonenvelop
virus
carri
insid
cytosol
infect
detect
result
proteasom
target
viru
induct
inflammatori
signal
process
depend
upon
mitochondri
antiviralsign
protein
mav
could
specul
intracellular
receptor
specif
immun
serum
protein
antivir
function
yet
discov
